In this review:
This article provides an overview of important pharmacological, dosage and administration, and clinical efficacy and tolerability properties and features of naltrexone/bupropion (Contrave® 8/90) in the treatment of adults who have overweight or obesity. This review is sponsored by an educational grant from Radiant New Zealand.
Download PDF